1 | inhibitor | 14,414 |
2 | inducer | 293 |
3 | inhibitor-based | 108 |
4 | 3β | 41 |
5 | inhibitor-induced | 39 |
6 | inhibitor/arb | 34 |
7 | inactivator | 15 |
8 | inhibitor-associated | 15 |
9 | inhibitor-related | 15 |
10 | inhibitor-containing | 14 |
11 | 3-monooxygenase | 11 |
12 | inhibitor-naive | 11 |
13 | inhibitor-sparing | 10 |
14 | breaker | 9 |
15 | inhibitor-free | 9 |
16 | inhibitor-resistant | 9 |
17 | aminobisphosphonate | 8 |
18 | inhibitor- | 8 |
19 | inhibitor-naïve | 8 |
20 | reactivators | 8 |
21 | inhibitor-intolerant | 7 |
22 | phac2ps | 7 |
23 | activation-mediated | 4 |
24 | exosite | 4 |
25 | inhibitor-experienced | 4 |
26 | inhibitor-metformin | 4 |
27 | inhibitor/diuretic | 4 |
28 | phosphatase-3 | 4 |
29 | div.1 | 3 |
30 | exo-β-1,3-glucanase | 3 |
31 | geneeskd | 3 |
32 | inhibitor-3 | 3 |
33 | inhibitor-arb | 3 |
34 | inhibitor-diuretic | 3 |
35 | inhibitor-dose | 3 |
36 | inhibitor-nitrate | 3 |
37 | inhibitor/substrate | 3 |
38 | 3α/β | 2 |
39 | adaptor-like | 2 |
40 | alpha-based | 2 |
41 | alpha-inhibitor | 2 |
42 | azaspiro | 2 |
43 | bcap8 | 2 |
44 | c-theta | 2 |
45 | cattarhalis | 2 |
46 | immuno-modulator | 2 |
47 | inhibitor-exposed | 2 |
48 | inhibitor-resistance | 2 |
49 | inhibitor-tolerant | 2 |
50 | inhibitor/r | 2 |
51 | inhibitor/ranitidine | 2 |
52 | inhibitors-based | 2 |
53 | ipad® | 2 |
54 | iu/0.4 | 2 |
55 | nanoplasmidexes | 2 |
56 | polypeptide-38 | 2 |
57 | δ-antagonist | 2 |
58 | +tac | 1 |
59 | .splitting | 1 |
60 | 1,2-dihydronaphthalene | 1 |
61 | 1,789+/-226 | 1 |
62 | 1-mutant | 1 |
63 | 1/2thr202/tyr204 | 1 |
64 | 1/solute-linked | 1 |
65 | 10876 | 1 |
66 | 1a2-catalyzed | 1 |
67 | 1ϵ | 1 |
68 | 2756 | 1 |
69 | 2c9-metabolized | 1 |
70 | 3,4-dioxygenases | 1 |
71 | 3-anca | 1 |
72 | 3-ancas | 1 |
73 | 3-ligand | 1 |
74 | 34g/g | 1 |
75 | 3a4-metabolized | 1 |
76 | 3a4/a5 | 1 |
77 | 4/c-jun | 1 |
78 | 5-kinases | 1 |
79 | a-phosphotransacetylase | 1 |
80 | a487p | 1 |
81 | activater | 1 |
82 | activity/level | 1 |
83 | alpha/il-1 | 1 |
84 | alpha1/2 | 1 |
85 | amphibole | 1 |
86 | assay-xenopus | 1 |
87 | b-cytoplasmic | 1 |
88 | b/akt1 | 1 |
89 | b/extracellular | 1 |
90 | balpha | 1 |
91 | biofertilzer | 1 |
92 | brc-abl | 1 |
93 | bromide/vilanterol | 1 |
94 | c-alpha | 1 |
95 | c-epsilon | 1 |
96 | c-zeta | 1 |
97 | c-ξ | 1 |
98 | c236 | 1 |
99 | c829t | 1 |
100 | cagonists | 1 |
101 | caldera-lake | 1 |
102 | cbeta | 1 |
103 | cbetaii | 1 |
104 | continuous-combines | 1 |
105 | cyclo-hexanecarboxamide | 1 |
106 | cζ | 1 |
107 | effect.similarly | 1 |
108 | etb-agonist | 1 |
109 | factor/cofilin | 1 |
110 | fobisin101 | 1 |
111 | g-protein-coupled-receptor | 1 |
112 | g1α | 1 |
113 | g1β | 1 |
114 | genes-metalloproteinase-2 | 1 |
115 | hemeoxygenase-2 | 1 |
116 | hsp-inducer | 1 |
117 | humanht-12 | 1 |
118 | iii/low-dose | 1 |
119 | immunoscore | 1 |
120 | imunostain | 1 |
121 | inhibitor+rtv+2nrtis | 1 |
122 | inhibitor+rtv+two | 1 |
123 | inhibitor-amoxicillin | 1 |
124 | inhibitor-b | 1 |
125 | inhibitor-comparator | 1 |
126 | inhibitor-dependent | 1 |
127 | inhibitor-drug | 1 |
128 | inhibitor-in | 1 |
129 | inhibitor-including | 1 |
130 | inhibitor-responsive | 1 |
131 | inhibitor-targeted | 1 |
132 | inhibitor.types | 1 |
133 | inhibitor/amoxicillin/clarithromycin | 1 |
134 | inhibitor/amoxicillin/metronidazole | 1 |
135 | inhibitor/nitrate | 1 |
136 | inhibitor/rbc | 1 |
137 | inhibitor/spironolactone | 1 |
138 | inhibitor2 | 1 |
139 | inhibitors-1,4-naphthoquinone | 1 |
140 | inhibitors-have | 1 |
141 | inhibitors/efavirenz | 1 |
142 | inhibitors/memantine | 1 |
143 | inhibitors/ritonavir | 1 |
144 | inhibitors=acei | 1 |
145 | inhibitors—vedolizumab | 1 |
146 | kinase-3α | 1 |
147 | l-ser | 1 |
148 | leucinal | 1 |
149 | levels/activation | 1 |
150 | lox-inhibition | 1 |
151 | m-band | 1 |
152 | mass-activating | 1 |
153 | mb-isoenzyme | 1 |
154 | member1 | 1 |
155 | misprogramming | 1 |
156 | mrck-1 | 1 |
157 | mycp3 | 1 |
158 | nonvariant | 1 |
159 | np03112 | 1 |
160 | osteoprotection | 1 |
161 | p-65 | 1 |
162 | peptide-lipid | 1 |
163 | pharmacoprofile | 1 |
164 | phosphatase-5 | 1 |
165 | pi3k-selective | 1 |
166 | propanediyl-1,3-bis | 1 |
167 | protein-b | 1 |
168 | psw-poly | 1 |
169 | rim15 | 1 |
170 | ring-dim | 1 |
171 | rs12678919 | 1 |
172 | rs1405952 | 1 |
173 | rs2279115 | 1 |
174 | rs328 | 1 |
175 | rs4149264 | 1 |
176 | rs699473 | 1 |
177 | rs715948 | 1 |
178 | s209d | 1 |
179 | s746a | 1 |
180 | sglt2-inhibitor | 1 |
181 | signaling/expression | 1 |
182 | skittles | 1 |
183 | slow-reversible | 1 |
184 | subunits-α | 1 |
185 | trichomonacides | 1 |
186 | type-1/th | 1 |
187 | type-5a | 1 |
188 | u73343 | 1 |
189 | vacuum-microwave | 1 |
190 | wss1 | 1 |
191 | yak1 | 1 |
192 | α=0.67 | 1 |
1 | +tac | 1 |
2 | .splitting | 1 |
3 | 1,2-dihydronaphthalene | 1 |
4 | 1,789+/-226 | 1 |
5 | 1-mutant | 1 |
6 | 1/2thr202/tyr204 | 1 |
7 | 1/solute-linked | 1 |
8 | 10876 | 1 |
9 | 1a2-catalyzed | 1 |
10 | 1ϵ | 1 |
11 | 2756 | 1 |
12 | 2c9-metabolized | 1 |
13 | 3,4-dioxygenases | 1 |
14 | 3-anca | 1 |
15 | 3-ancas | 1 |
16 | 3-ligand | 1 |
17 | 3-monooxygenase | 11 |
18 | 34g/g | 1 |
19 | 3a4-metabolized | 1 |
20 | 3a4/a5 | 1 |
21 | 3α/β | 2 |
22 | 3β | 41 |
23 | 4/c-jun | 1 |
24 | 5-kinases | 1 |
25 | a-phosphotransacetylase | 1 |
26 | a487p | 1 |
27 | activater | 1 |
28 | activation-mediated | 4 |
29 | activity/level | 1 |
30 | adaptor-like | 2 |
31 | alpha-based | 2 |
32 | alpha-inhibitor | 2 |
33 | alpha/il-1 | 1 |
34 | alpha1/2 | 1 |
35 | aminobisphosphonate | 8 |
36 | amphibole | 1 |
37 | assay-xenopus | 1 |
38 | azaspiro | 2 |
39 | b-cytoplasmic | 1 |
40 | b/akt1 | 1 |
41 | b/extracellular | 1 |
42 | balpha | 1 |
43 | bcap8 | 2 |
44 | biofertilzer | 1 |
45 | brc-abl | 1 |
46 | breaker | 9 |
47 | bromide/vilanterol | 1 |
48 | c-alpha | 1 |
49 | c-epsilon | 1 |
50 | c-theta | 2 |
51 | c-zeta | 1 |
52 | c-ξ | 1 |
53 | c236 | 1 |
54 | c829t | 1 |
55 | cagonists | 1 |
56 | caldera-lake | 1 |
57 | cattarhalis | 2 |
58 | cbeta | 1 |
59 | cbetaii | 1 |
60 | continuous-combines | 1 |
61 | cyclo-hexanecarboxamide | 1 |
62 | cζ | 1 |
63 | div.1 | 3 |
64 | effect.similarly | 1 |
65 | etb-agonist | 1 |
66 | exo-β-1,3-glucanase | 3 |
67 | exosite | 4 |
68 | factor/cofilin | 1 |
69 | fobisin101 | 1 |
70 | g-protein-coupled-receptor | 1 |
71 | g1α | 1 |
72 | g1β | 1 |
73 | geneeskd | 3 |
74 | genes-metalloproteinase-2 | 1 |
75 | hemeoxygenase-2 | 1 |
76 | hsp-inducer | 1 |
77 | humanht-12 | 1 |
78 | iii/low-dose | 1 |
79 | immuno-modulator | 2 |
80 | immunoscore | 1 |
81 | imunostain | 1 |
82 | inactivator | 15 |
83 | inducer | 293 |
84 | inhibitor | 14,414 |
85 | inhibitor+rtv+2nrtis | 1 |
86 | inhibitor+rtv+two | 1 |
87 | inhibitor- | 8 |
88 | inhibitor-3 | 3 |
89 | inhibitor-amoxicillin | 1 |
90 | inhibitor-arb | 3 |
91 | inhibitor-associated | 15 |
92 | inhibitor-b | 1 |
93 | inhibitor-based | 108 |
94 | inhibitor-comparator | 1 |
95 | inhibitor-containing | 14 |
96 | inhibitor-dependent | 1 |
97 | inhibitor-diuretic | 3 |
98 | inhibitor-dose | 3 |
99 | inhibitor-drug | 1 |
100 | inhibitor-experienced | 4 |
101 | inhibitor-exposed | 2 |
102 | inhibitor-free | 9 |
103 | inhibitor-in | 1 |
104 | inhibitor-including | 1 |
105 | inhibitor-induced | 39 |
106 | inhibitor-intolerant | 7 |
107 | inhibitor-metformin | 4 |
108 | inhibitor-naive | 11 |
109 | inhibitor-naïve | 8 |
110 | inhibitor-nitrate | 3 |
111 | inhibitor-related | 15 |
112 | inhibitor-resistance | 2 |
113 | inhibitor-resistant | 9 |
114 | inhibitor-responsive | 1 |
115 | inhibitor-sparing | 10 |
116 | inhibitor-targeted | 1 |
117 | inhibitor-tolerant | 2 |
118 | inhibitor.types | 1 |
119 | inhibitor/amoxicillin/clarithromycin | 1 |
120 | inhibitor/amoxicillin/metronidazole | 1 |
121 | inhibitor/arb | 34 |
122 | inhibitor/diuretic | 4 |
123 | inhibitor/nitrate | 1 |
124 | inhibitor/r | 2 |
125 | inhibitor/ranitidine | 2 |
126 | inhibitor/rbc | 1 |
127 | inhibitor/spironolactone | 1 |
128 | inhibitor/substrate | 3 |
129 | inhibitor2 | 1 |
130 | inhibitors-1,4-naphthoquinone | 1 |
131 | inhibitors-based | 2 |
132 | inhibitors-have | 1 |
133 | inhibitors/efavirenz | 1 |
134 | inhibitors/memantine | 1 |
135 | inhibitors/ritonavir | 1 |
136 | inhibitors=acei | 1 |
137 | inhibitors—vedolizumab | 1 |
138 | ipad® | 2 |
139 | iu/0.4 | 2 |
140 | kinase-3α | 1 |
141 | l-ser | 1 |
142 | leucinal | 1 |
143 | levels/activation | 1 |
144 | lox-inhibition | 1 |
145 | m-band | 1 |
146 | mass-activating | 1 |
147 | mb-isoenzyme | 1 |
148 | member1 | 1 |
149 | misprogramming | 1 |
150 | mrck-1 | 1 |
151 | mycp3 | 1 |
152 | nanoplasmidexes | 2 |
153 | nonvariant | 1 |
154 | np03112 | 1 |
155 | osteoprotection | 1 |
156 | p-65 | 1 |
157 | peptide-lipid | 1 |
158 | phac2ps | 7 |
159 | pharmacoprofile | 1 |
160 | phosphatase-3 | 4 |
161 | phosphatase-5 | 1 |
162 | pi3k-selective | 1 |
163 | polypeptide-38 | 2 |
164 | propanediyl-1,3-bis | 1 |
165 | protein-b | 1 |
166 | psw-poly | 1 |
167 | reactivators | 8 |
168 | rim15 | 1 |
169 | ring-dim | 1 |
170 | rs12678919 | 1 |
171 | rs1405952 | 1 |
172 | rs2279115 | 1 |
173 | rs328 | 1 |
174 | rs4149264 | 1 |
175 | rs699473 | 1 |
176 | rs715948 | 1 |
177 | s209d | 1 |
178 | s746a | 1 |
179 | sglt2-inhibitor | 1 |
180 | signaling/expression | 1 |
181 | skittles | 1 |
182 | slow-reversible | 1 |
183 | subunits-α | 1 |
184 | trichomonacides | 1 |
185 | type-1/th | 1 |
186 | type-5a | 1 |
187 | u73343 | 1 |
188 | vacuum-microwave | 1 |
189 | wss1 | 1 |
190 | yak1 | 1 |
191 | α=0.67 | 1 |
192 | δ-antagonist | 2 |
1 | inhibitor- | 8 |
2 | mrck-1 | 1 |
3 | alpha/il-1 | 1 |
4 | div.1 | 3 |
5 | fobisin101 | 1 |
6 | yak1 | 1 |
7 | member1 | 1 |
8 | wss1 | 1 |
9 | b/akt1 | 1 |
10 | hemeoxygenase-2 | 1 |
11 | genes-metalloproteinase-2 | 1 |
12 | alpha1/2 | 1 |
13 | humanht-12 | 1 |
14 | np03112 | 1 |
15 | rs1405952 | 1 |
16 | inhibitor2 | 1 |
17 | phosphatase-3 | 4 |
18 | inhibitor-3 | 3 |
19 | u73343 | 1 |
20 | rs699473 | 1 |
21 | mycp3 | 1 |
22 | iu/0.4 | 2 |
23 | 1/2thr202/tyr204 | 1 |
24 | rs4149264 | 1 |
25 | phosphatase-5 | 1 |
26 | rs2279115 | 1 |
27 | rim15 | 1 |
28 | p-65 | 1 |
29 | 3a4/a5 | 1 |
30 | 1,789+/-226 | 1 |
31 | c236 | 1 |
32 | 2756 | 1 |
33 | 10876 | 1 |
34 | α=0.67 | 1 |
35 | rs328 | 1 |
36 | polypeptide-38 | 2 |
37 | rs715948 | 1 |
38 | bcap8 | 2 |
39 | rs12678919 | 1 |
40 | type-5a | 1 |
41 | s746a | 1 |
42 | 3-anca | 1 |
43 | c-alpha | 1 |
44 | balpha | 1 |
45 | cbeta | 1 |
46 | c-theta | 2 |
47 | c-zeta | 1 |
48 | protein-b | 1 |
49 | inhibitor-b | 1 |
50 | inhibitors—vedolizumab | 1 |
51 | inhibitor-arb | 3 |
52 | inhibitor/arb | 34 |
53 | +tac | 1 |
54 | inhibitor/rbc | 1 |
55 | b-cytoplasmic | 1 |
56 | inhibitor-diuretic | 3 |
57 | inhibitor/diuretic | 4 |
58 | s209d | 1 |
59 | inhibitor-experienced | 4 |
60 | inhibitor-induced | 39 |
61 | 1/solute-linked | 1 |
62 | alpha-based | 2 |
63 | inhibitor-based | 108 |
64 | inhibitors-based | 2 |
65 | inhibitor-exposed | 2 |
66 | inhibitor-associated | 15 |
67 | activation-mediated | 4 |
68 | inhibitor-related | 15 |
69 | inhibitor-targeted | 1 |
70 | 3a4-metabolized | 1 |
71 | 2c9-metabolized | 1 |
72 | 1a2-catalyzed | 1 |
73 | peptide-lipid | 1 |
74 | geneeskd | 3 |
75 | m-band | 1 |
76 | 3-ligand | 1 |
77 | inhibitor-resistance | 2 |
78 | cyclo-hexanecarboxamide | 1 |
79 | inhibitor-free | 9 |
80 | caldera-lake | 1 |
81 | adaptor-like | 2 |
82 | slow-reversible | 1 |
83 | pharmacoprofile | 1 |
84 | amphibole | 1 |
85 | inhibitor/amoxicillin/metronidazole | 1 |
86 | mb-isoenzyme | 1 |
87 | 1,2-dihydronaphthalene | 1 |
88 | inhibitor/ranitidine | 2 |
89 | inhibitors/memantine | 1 |
90 | inhibitors-1,4-naphthoquinone | 1 |
91 | inhibitor/spironolactone | 1 |
92 | immunoscore | 1 |
93 | a-phosphotransacetylase | 1 |
94 | exo-β-1,3-glucanase | 3 |
95 | 3-monooxygenase | 11 |
96 | inhibitor-dose | 3 |
97 | iii/low-dose | 1 |
98 | aminobisphosphonate | 8 |
99 | inhibitor-nitrate | 3 |
100 | inhibitor/nitrate | 1 |
101 | inhibitor/substrate | 3 |
102 | exosite | 4 |
103 | inhibitors-have | 1 |
104 | vacuum-microwave | 1 |
105 | inhibitor-naive | 11 |
106 | inhibitor-responsive | 1 |
107 | pi3k-selective | 1 |
108 | inhibitor-naïve | 8 |
109 | 34g/g | 1 |
110 | inhibitor-including | 1 |
111 | misprogramming | 1 |
112 | inhibitor-containing | 14 |
113 | inhibitor-sparing | 10 |
114 | mass-activating | 1 |
115 | .splitting | 1 |
116 | inhibitor-drug | 1 |
117 | type-1/th | 1 |
118 | inhibitors=acei | 1 |
119 | cbetaii | 1 |
120 | leucinal | 1 |
121 | brc-abl | 1 |
122 | activity/level | 1 |
123 | bromide/vilanterol | 1 |
124 | ring-dim | 1 |
125 | inhibitor-in | 1 |
126 | imunostain | 1 |
127 | inhibitor/amoxicillin/clarithromycin | 1 |
128 | factor/cofilin | 1 |
129 | inhibitor-amoxicillin | 1 |
130 | inhibitor-metformin | 4 |
131 | signaling/expression | 1 |
132 | levels/activation | 1 |
133 | osteoprotection | 1 |
134 | lox-inhibition | 1 |
135 | c-epsilon | 1 |
136 | 4/c-jun | 1 |
137 | azaspiro | 2 |
138 | inhibitor+rtv+two | 1 |
139 | a487p | 1 |
140 | inhibitor/r | 2 |
141 | b/extracellular | 1 |
142 | inducer | 293 |
143 | hsp-inducer | 1 |
144 | breaker | 9 |
145 | l-ser | 1 |
146 | activater | 1 |
147 | biofertilzer | 1 |
148 | inhibitors/ritonavir | 1 |
149 | immuno-modulator | 2 |
150 | inhibitor-comparator | 1 |
151 | inactivator | 15 |
152 | inhibitor | 14,414 |
153 | sglt2-inhibitor | 1 |
154 | alpha-inhibitor | 2 |
155 | g-protein-coupled-receptor | 1 |
156 | 3-ancas | 1 |
157 | trichomonacides | 1 |
158 | skittles | 1 |
159 | continuous-combines | 1 |
160 | inhibitor.types | 1 |
161 | 3,4-dioxygenases | 1 |
162 | 5-kinases | 1 |
163 | nanoplasmidexes | 2 |
164 | propanediyl-1,3-bis | 1 |
165 | cattarhalis | 2 |
166 | inhibitor+rtv+2nrtis | 1 |
167 | phac2ps | 7 |
168 | reactivators | 8 |
169 | cagonists | 1 |
170 | assay-xenopus | 1 |
171 | c829t | 1 |
172 | nonvariant | 1 |
173 | inhibitor-tolerant | 2 |
174 | inhibitor-intolerant | 7 |
175 | inhibitor-resistant | 9 |
176 | 1-mutant | 1 |
177 | inhibitor-dependent | 1 |
178 | etb-agonist | 1 |
179 | δ-antagonist | 2 |
180 | psw-poly | 1 |
181 | effect.similarly | 1 |
182 | inhibitors/efavirenz | 1 |
183 | ipad® | 2 |
184 | subunits-α | 1 |
185 | g1α | 1 |
186 | kinase-3α | 1 |
187 | 3α/β | 2 |
188 | g1β | 1 |
189 | 3β | 41 |
190 | 1ϵ | 1 |
191 | cζ | 1 |
192 | c-ξ | 1 |